Levotuss

Levodropropizine, the active ingredient in Levotuss, is a peripherally acting antitussive presented as an oral formulation for oral use. It relieves dry, non‑productive coughs in adults and children when appropriate.

GNH USA supplies Levotuss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodropropizine acts on the peripheral cough pathway to provide symptomatic relief of cough. - Dry cough: reduces frequency and intensity of coughing episodes. - Non‑productive cough: suppresses the cough reflex without affecting mucus clearance. - Upper respiratory tract infection‑related cough: offers symptomatic relief of irritation‑driven cough.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset reported by some users. - Dizziness: transient light‑headedness. - Headache: occasional mild headache. - Gastrointestinal discomfort: mild abdominal pain or dyspepsia. - Taste alteration: temporary change in taste perception. - Somnolence: mild sleepiness.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or urticaria. - Angioedema: swelling of face, lips, or tongue. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: signs of liver dysfunction. - Anaphylaxis: rare life‑threatening hypersensitivity. - Neutropenia: low white blood cell count.

When using Levotuss, consider the following precautions to ensure safe use. - Age restrictions: use in children only under medical supervision and according to prescribed age limits. - Hepatic impairment: dose adjustment may be required; monitor liver function. - Concomitant CNS depressants: caution as additive sedation may occur. - Known hypersensitivity: avoid if allergic to levodropropizine or excipients. - Pregnancy and breastfeeding: safety not established; use only if benefit outweighs risk. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levodropropizine may interact with other medicines; be aware of the following.

Major Interactions (Avoid): - Other antitussives (e.g., codeine, dextromethorphan): additive cough suppression and increased risk of sedation. - Strong CYP3A4 inhibitors (if metabolized via this pathway): may raise levodropropizine plasma levels.

Moderate Interactions (Monitor Closely): - Sedating antihistamines: may enhance drowsiness. - Alcohol: can increase central nervous system effects. - Bronchodilators: monitor for any change in cough relief efficacy. - Certain antibiotics (e.g., macrolides): observe for possible pharmacokinetic changes.